Profile data is unavailable for this security.
About the company
Cannara Biotech Inc. is a Canada-based vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. It operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The Company owns two mega facilities based in Quebec spanning over 1,650,000 square feet, providing the Company with 100,000 kilograms of annualized cultivation output. It operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations, which encompasses the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and other cannabis services (Cannabis operations). The Real estate operations, related to the Farnham and Valleyfield building (Real estate operations). The Company’s brand portfolio includes Tribal, Nugz, and Orchid CBD. Orchid CBD is a wellness brand that provides premium CBD-dominant cannabis.
- Revenue in CAD (TTM)73.38m
- Net income in CAD6.22m
- Incorporated2017
- Employees--
- LocationCannara Biotech IncSuite 2050 - 1055, West Georgia StreetVANCOUVER V6E 3P3CanadaCAN
- Phone+1 (514) 913-9136
- Fax+1 (514) 913-9136
- Websitehttps://www.cannara.ca/en/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Microbix Biosystems Inc | 23.84m | 4.06m | 45.83m | 69.00 | 11.33 | 1.66 | 8.39 | 1.92 | 0.0296 | 0.0296 | 0.173 | 0.202 | 0.6703 | 1.67 | 6.33 | -- | 11.42 | -0.9729 | 12.72 | -1.17 | 54.38 | 52.30 | 17.04 | -1.55 | 4.98 | 3.53 | 0.1948 | -- | -13.43 | 5.71 | -102.21 | -- | -3.56 | -- |
| Nurexone Biologic Inc | 0.00 | -5.27m | 48.86m | 8.00 | -- | 9.66 | -- | -- | -0.1126 | -0.1126 | 0.00 | 0.0753 | 0.00 | -- | -- | -- | -124.70 | -213.78 | -146.79 | -596.97 | -- | -- | -- | -- | -- | -- | 0.0066 | -- | -- | -- | 55.45 | -- | -- | -- |
| KDA Group Inc | 186.28k | 133.66k | 50.87m | -- | 144.28 | 3.27 | 58.22 | 273.06 | 0.002 | 0.0926 | 0.0012 | 0.0886 | 0.0079 | -- | 0.0693 | -- | -0.4146 | -17.96 | -0.8534 | -44.69 | 36.51 | 26.76 | -52.24 | -28.00 | -- | -4.31 | 0.1287 | -- | -22.20 | -62.03 | 106.88 | -- | 31.67 | -- |
| LSL Pharma Group Inc | 12.17m | -4.62m | 51.84m | -- | -- | 3.22 | -- | 4.26 | -0.056 | -0.056 | 0.1466 | 0.1489 | 0.3929 | 2.59 | 4.87 | -- | -14.92 | -- | -21.69 | -- | 19.76 | -- | -37.97 | -- | 0.4505 | -0.8465 | 0.4938 | -- | -- | -- | -- | -- | -- | -- |
| Covalon Technologies Ltd | 26.24m | -2.77m | 51.89m | -- | -- | 2.58 | -- | 1.98 | -0.1123 | -0.1123 | 1.06 | 0.8021 | 1.02 | 1.84 | 4.53 | -- | -10.83 | -18.06 | -12.67 | -27.10 | 55.84 | 51.89 | -10.57 | -27.06 | 4.85 | -- | 0.0597 | -- | 46.56 | -0.096 | 51.79 | -- | 12.21 | -- |
| Helix Biopharma Corp. | 0.00 | -6.14m | 56.37m | 9.00 | -- | -- | -- | -- | -0.0296 | -0.0296 | 0.00 | -0.0016 | 0.00 | -- | -- | 0.00 | -449.73 | -261.49 | -2,225.00 | -- | -- | -- | -- | -- | -- | -265.96 | -- | -- | -- | -- | 4.16 | -- | -28.36 | -- |
| Medmira Inc | 407.78k | -2.92m | 57.46m | 65.00 | -- | -- | -- | 140.92 | -0.0042 | -0.0042 | 0.0006 | -0.0229 | 0.0996 | 0.7899 | 0.3142 | -- | -71.41 | -69.95 | -- | -- | 61.54 | 66.76 | -717.02 | -187.61 | 0.1342 | -2.09 | -- | -- | -54.57 | -5.98 | -46.08 | -- | -- | -- |
| Cannara Biotech Inc | 73.38m | 6.22m | 61.21m | -- | 9.79 | 0.7715 | 5.15 | 0.8342 | 0.0695 | 0.0695 | 0.8173 | 0.8814 | 0.5337 | 2.08 | 7.46 | -- | 4.52 | -4.46 | 6.23 | -4.95 | 10.06 | 17.86 | 8.48 | -15.88 | 0.3582 | -2.46 | 0.384 | -- | 59.91 | -- | 201.26 | -- | -- | -- |
| Satellos Bioscience Inc | 0.00 | -21.13m | 63.16m | 12.00 | -- | 1.83 | -- | -- | -0.1718 | -0.1718 | 0.00 | 0.3059 | 0.00 | -- | -- | 0.00 | -93.29 | -107.22 | -109.86 | -136.58 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -40.33 | -- | 459.46 | -- |
| Simply Better Brands Corp | 94.52m | -29.84m | 64.61m | -- | -- | -- | -- | 0.6836 | -0.4131 | -0.428 | 1.31 | -0.0848 | 2.71 | 12.68 | 17.69 | -- | -85.10 | -63.90 | -361.23 | -215.48 | 53.52 | -- | -31.40 | -29.46 | 0.2536 | -19.65 | 3.20 | -- | 22.08 | -- | -96.41 | -- | -- | -- |
| ZYUS Life Sciences Corp | 387.00k | -41.25m | 71.56m | 2.00 | -- | 3.57 | -- | 184.90 | -0.5751 | -0.5751 | 0.0057 | 0.2833 | 0.0165 | -- | 0.7911 | -- | -175.44 | -57.88 | -242.41 | -71.19 | 46.25 | -16.16 | -10,658.40 | -10,367.37 | 0.315 | -7.99 | 0.3295 | -- | 17.79 | 213.99 | -72.73 | -- | -- | -- |
